Pharmaceuticals, Biotechnology and Life Sciences
Data from ongoing Phase 1 extension study shows improvement in disease features or disease stabilization with home-based intravenous infusions of…
Data from ongoing Phase 1 extension study shows improvement in disease features or disease stabilization with home-based intravenous infusions of…
CHICAGO–(BUSINESS WIRE)–#AI—physIQ, Inc. and the US Department of Veteran’s Affairs (VA) have advanced their collaboration to address heart failure care…
NOTTINGHAM, England–(BUSINESS WIRE)–Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract…
NOTTINGHAM, England–(BUSINESS WIRE)–Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract…
BERKELEY, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome editing biotechnology company, announced today the appointment of Jason O’Byrne…
Multicenter study of the efficacy, safety, tolerability, and pharmacokinetics of PlasmaCap IG in adults and children with primary immune deficiency…
Minimally Invasive creates a new product category in breast aesthetics with a total addressable market of $4-5 billion Clinical study…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#ImagoBiosciences—Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–#ImagoBiosciences—Imago BioSciences, Inc. (Imago), a clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, today…